Ipca Laboratories reports 31% fall in Q1 consolidated net profit

05 Aug 2021 Evaluate

Ipca Laboratories has reported results for first quarter ended June 30, 2021.

The company has reported a fall of 37.24% in its net profit at Rs 284.72 crore for the quarter under review as compared to Rs 453.64 crore for the same quarter in the previous year. Total income of the company decreased by 0.32% at Rs 1,492.21 crore for Q1FY22 as compared Rs 1496.93 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 31.26% in its net profit attributed to the owners at Rs 306.66 crore for the quarter under review as compared to Rs 446.13 crore for the same quarter in the previous year. However, total income of the company increased by 2.61% at Rs 1,586.81 crore for Q1FY22 as compared Rs 1,546.49 crore for the corresponding quarter previous year.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×